Publication not explained
This publication has not yet been explained in plain language by the author(s). However, you can still read the publication.
If you are one of the authors, claim this publication so you can create a plain language summary to help more people find, understand and use it.
Featured Image
Read the Original
This page is a summary of: Clinical impact of KMT2C and SPRY4 expression levels in intensively treated younger adult acute myeloid leukemia patients, European Journal Of Haematology, October 2017, Wiley,
DOI: 10.1111/ejh.12972.
You can read the full text:
Contributors
The following have contributed to this page